Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
perfluorocarbon-based oxygen therapeutic
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:alternativeTo |
blood transfusion
|
| gptkbp:CASNumber |
31808-00-5
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:composition |
perfluorocarbon emulsion
|
| gptkbp:developedBy |
gptkb:Oxygen_Biotherapeutics,_Inc.
|
| https://www.w3.org/2000/01/rdf-schema#label |
Oxycyte
|
| gptkbp:status |
investigational drug
|
| gptkbp:usedFor |
oxygen delivery
treatment of decompression sickness treatment of traumatic brain injury |
| gptkbp:bfsParent |
gptkb:Blood_Substitute
|
| gptkbp:bfsLayer |
7
|